Azenta to Acquire German Thawing Devices Provider Barkey Holding.

MANews-(C)2009-2022

US-based life sciences solutions provider Azenta, Inc. (NASDAQ: AZTA) has entered into a definitive agreement to acquire Germany-based Barkey Holding GmbH and its subsidiaries, a provider of controlled rate thawing devices to medical, biotech and pharma industries, the company said.

Barkey is headquartered in LeopoldshÃ[pilcrow sign]he, Germany.

Barkey has over four decades of expertise in the automated thawing of plasma, blood and stem cells and has more recently focused on cell and gene therapy applications.

Its key product lines are used for controlled rate thawing of cryopreserved samples and therapies.

These products are used in R and D, clinical trials, GMP manufacturing and in hospitals.

Barkey's plasmatherm product is an automated cell thawing device approved by the FDA as a medical device for clinical use.

The total cash purchase price for the acquisition will be approximately EUR 80m (USD 85.06m).

The transaction is expected to close in early July upon satisfaction of customary closing conditions.

Co-owners Chris Barkey and Thomas Barkey, and COO Armin Nowack, who have led the company for over 20 years, will join Azenta and continue to lead the business as part of the Life Sciences Products segment.

Barkey generated...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT